Margarita Kushnir

Margarita Kushnir

Hematology

1920 North Higley Road
Suite 108
Gilbert, AZ 85234

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Acute Renal Thrombotic Microangiopathy Caused by Eltrombopag and Romiplostim in a Patient with Myelodysplastic Syndromes (MDS) and Underlying Antiphospholipid Syndrome.

Acute Renal Thrombotic Microangiopathy Caused by Eltrombopag and Romiplostim in a Patient with Myelodysplastic Syndromes (MDS) and Underlying Antiphospholipid Syndrome.

Journal: European journal of case reports in internal medicine

Published: April 17, 2024

Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear Autoanalyzers.

Identifying Neutrophil Extracellular Traps (NETs) in Blood Samples Using Peripheral Smear Autoanalyzers.

Journal: Life (Basel, Switzerland)

Published: February 08, 2023

Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery.

Direct oral Xa inhibitors for the treatment of venous thromboembolism after bariatric surgery.

Journal: Blood advances

Published: November 24, 2021

Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes.

Saddle Pulmonary Embolism: Demographics, Clinical Presentation, and Outcomes.

Journal: Critical care explorations

Published: June 17, 2021

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists.

Thrombosis in myeloproliferative neoplasms: Treatment outcomes of direct oral anticoagulants and vitamin K antagonists.

Journal: Research and practice in thrombosis and haemostasis

Published: January 04, 2021

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality.

Journal: Thrombosis and haemostasis

Published: November 13, 2020

Direct oral factor Xa inhibitors in patients with morbid obesity - Author's reply.

Direct oral factor Xa inhibitors in patients with morbid obesity - Author's reply.

Journal: The Lancet. Haematology

Published: August 13, 2019

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.

Efficacy and safety of direct oral factor Xa inhibitors compared with warfarin in patients with morbid obesity: a single-centre, retrospective analysis of chart data.

Journal: The Lancet. Haematology

Published: January 25, 2019

Persistent neutrophilia is a marker for an increased risk of venous thrombosis.

Persistent neutrophilia is a marker for an increased risk of venous thrombosis.

Journal: Journal of thrombosis and thrombolysis

Published: July 08, 2016

Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency.

Treatment with Dalteparin is Associated with a Lower Risk of Bleeding Compared to Treatment with Unfractionated Heparin in Patients with Renal Insufficiency.

Journal: Journal of general internal medicine

Published: January 06, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026